Global Epidemiology of Chronic Liver Disease.
作者信息
Cheemerla Shantan, Balakrishnan Maya
机构信息
Department of Internal Medicine Baylor College of Medicine Houston TX.
Section of Gastroenterology & Hepatology Baylor College of Medicine Houston TX.
出版信息
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. eCollection 2021 May.
Abstract
摘要
相似文献
1
Global Epidemiology of Chronic Liver Disease.慢性肝病的全球流行病学
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. eCollection 2021 May.
2
Gallstones in Patients with Chronic Liver Diseases.慢性肝病患者的胆结石
Biomed Res Int. 2017;2017:9749802. doi: 10.1155/2017/9749802. Epub 2017 Jan 31.
3
The evolving epidemiology of hepatocellular carcinoma: a global perspective.肝细胞癌不断演变的流行病学：全球视角
Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):765-79. doi: 10.1586/17474124.2015.1028363. Epub 2015 Apr 1.
4
Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure.慢性肝功能衰竭急性发作的流行病学及医疗负担
Semin Liver Dis. 2016 May;36(2):123-6. doi: 10.1055/s-0036-1583201. Epub 2016 May 12.
5
Epidemiology and prophylaxis of viral hepatitis: a global perspective.病毒性肝炎的流行病学与预防：全球视角
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S155-66. doi: 10.1046/j.1440-1746.17.s1.4.x.
6
[Advances in epidemiology and serum markers for the noninvasive diagnosis of nonalcoholic fatty liver disease].[非酒精性脂肪性肝病无创诊断的流行病学及血清标志物研究进展]
Zhonghua Gan Zang Bing Za Zhi. 2018 Jun 20;26(6):476-480. doi: 10.3760/cma.j.issn.1007-3418.2018.06.020.
7
Acute-on-chronic and Decompensated Chronic Liver Failure: Definitions, Epidemiology, and Prognostication.急性-on-慢性和失代偿性慢性肝衰竭：定义、流行病学及预后评估
Crit Care Clin. 2016 Jul;32(3):301-9. doi: 10.1016/j.ccc.2016.02.001.
8
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.《全球疾病负担研究》分析强调了 1990 年至 2016 年期间全球、地区和国家慢性肾脏病流行病学的趋势。
Kidney Int. 2018 Sep;94(3):567-581. doi: 10.1016/j.kint.2018.04.011. Epub 2018 Aug 3.
9
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.全球 2 型糖尿病患者非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学：系统评价和荟萃分析。
J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.
10
Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control.第2章. 片形吸虫、椎实螺与人类片形吸虫病，对疾病传播、流行病学、进化遗传学、分子流行病学及防控进行全球概述。
Adv Parasitol. 2009;69:41-146. doi: 10.1016/S0065-308X(09)69002-3.
引用本文的文献
1
Mucosal microbiota signatures reveal diagnostic insights in chronic liver disease.黏膜微生物群特征揭示了慢性肝病的诊断线索。
BMC Gastroenterol. 2025 Aug 21;25(1):607. doi: 10.1186/s12876-025-04204-3.
2
Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports.慢性肝病患者注射人胎盘提取物后肝功能改善：30例病例报告。
World J Clin Cases. 2025 Aug 16;13(23):102937. doi: 10.12998/wjcc.v13.i23.102937.
3
A Review of Natural Products Against Alcoholic Liver Fibrosis.天然产物抗酒精性肝纤维化研究综述
Turk J Gastroenterol. 2025 Aug 1;36(8):479-487. doi: 10.5152/tjg.2025.25154.
4
Role of platelet counts to spleen length ratio and platelet-albumin to spleen length ratio as non-invasive predictors of esophageal varices in chronic liver disease patients: A cross-sectional study in Eastern India.血小板计数与脾脏长度比值及血小板-白蛋白与脾脏长度比值作为慢性肝病患者食管静脉曲张无创预测指标的作用：印度东部的一项横断面研究
J Family Med Prim Care. 2025 Jul;14(7):2987-2996. doi: 10.4103/jfmpc.jfmpc_2032_24. Epub 2025 Jul 21.
5
Performance and Selectivity toward Acetone against Various Gaseous Markers for Liver Diseases of Flame-Made Ir-Loaded InO Nanoparticulate Sensors.火焰制备的负载铱的氧化铟纳米颗粒传感器对丙酮相对于各种肝病气体标志物的性能和选择性
ACS Sens. 2025 Aug 22;10(8):5748-5759. doi: 10.1021/acssensors.5c00888. Epub 2025 Aug 7.
6
Association between exposure to air pollutants and NAFLD/MAFLD: a meta-analysis.空气污染物暴露与非酒精性脂肪性肝病/代谢功能障碍相关脂肪性肝病之间的关联：一项荟萃分析。
BMC Public Health. 2025 Aug 6;25(1):2672. doi: 10.1186/s12889-025-24058-4.
7
Vitamin D Deficiency and Chronic Liver Disease: Investigating Predictive Factors and Their Implications for Patient Care in Pakistan.维生素D缺乏与慢性肝病：探究巴基斯坦的预测因素及其对患者护理的影响。
Iran J Public Health. 2025 May;54(5):1054-1063. doi: 10.18502/ijph.v54i5.18640.
8
Role of Iron Metabolic Disturbances and Inflammatory Iron Biomarkers in Liver Transplant Prognosis.铁代谢紊乱及炎症性铁生物标志物在肝移植预后中的作用
Int J Med Sci. 2025 Jul 1;22(13):3202-3219. doi: 10.7150/ijms.113479. eCollection 2025.
9
The Role of Dandelion () in Liver Health and Hepatoprotective Properties.蒲公英在肝脏健康及肝脏保护特性中的作用
Pharmaceuticals (Basel). 2025 Jul 1;18(7):990. doi: 10.3390/ph18070990.
10
Alginate/Arabic gum-chitosan-encapsulated Bacillus subtilis enhances probiotic viability and alleviates liver injury and fibrosis in cholestatic rats.海藻酸钠/阿拉伯胶-壳聚糖包封的枯草芽孢杆菌可提高益生菌活力，并减轻胆汁淤积性大鼠的肝损伤和肝纤维化。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 22. doi: 10.1007/s00210-025-04452-w.
本文引用的文献
1
The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection.美国及全球丙型肝炎病毒感染直接抗病毒治疗方案的可及现状
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):16-19. doi: 10.1002/cld.925. eCollection 2020 Jul.
2
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.非酒精性和酒精性脂肪性肝病的流行病学
Transl Gastroenterol Hepatol. 2020 Apr 5;5:16. doi: 10.21037/tgh.2019.09.08. eCollection 2020.
3
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究：1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担：系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
4
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.慢性肝病和肝硬化的当代流行病学。
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2650-2666. doi: 10.1016/j.cgh.2019.07.060. Epub 2019 Aug 8.
5
Epidemiology of Alcohol Use and Alcoholic Liver Disease.酒精使用与酒精性肝病的流行病学
Clin Liver Dis (Hoboken). 2019 May 31;13(5):136-139. doi: 10.1002/cld.806. eCollection 2019 May.
6
Epidemiology of Hepatitis C.丙型肝炎流行病学
Clin Liver Dis (Hoboken). 2018 Dec 14;12(5):140-142. doi: 10.1002/cld.783. eCollection 2018 Nov.
7
Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges.实现世界卫生组织和美国到2030年消除乙型肝炎感染的目标：机遇与挑战。
Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):29-32. doi: 10.1002/cld.733. eCollection 2018 Jul.
8
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.加速消除病毒性肝炎：柳叶刀胃肠病学和肝脏病学委员会报告
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135-184. doi: 10.1016/S2468-1253(18)30270-X.
9
Hepatitis elimination by 2030: Progress and challenges.2030 年消除肝炎：进展与挑战。
World J Gastroenterol. 2018 Nov 28;24(44):4959-4961. doi: 10.3748/wjg.v24.i44.4959.
10
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学：对肝移植的影响。
Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.
Zotero 插件